Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Roche Diagnostics
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott Laboratories
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Siemens Healthineers
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Nova Biomedical
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Bionime
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Sinocare
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Medtronic
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. LifeScan
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. ACON Laboratories
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Ypsomed Holding AG
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE DIAGNOSTICS: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. SIEMENS HEALTHINEERS: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. NOVA BIOMEDICAL: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. NOVA BIOMEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. BIONIME: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. BIONIME: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. BIONIME: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. SINOCARE: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. SINOCARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. SINOCARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. MEDTRONIC: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. LIFESCAN: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. LIFESCAN: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. LIFESCAN: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ACON LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. ACON LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ACON LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. YPSOMED HOLDING AG: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. YPSOMED HOLDING AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. YPSOMED HOLDING AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 05. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 06. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 07. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 08. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 09. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 10. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 11. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 12. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 13. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 14. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 15. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 16. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 17. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 18. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 19. NOVA BIOMEDICAL: KEY EXECUTIVES
TABLE 20. NOVA BIOMEDICAL: COMPANY SNAPSHOT
TABLE 21. NOVA BIOMEDICAL: OPERATING SEGMENTS
TABLE 22. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 23. NOVA BIOMEDICAL: KEY STRATERGIES
TABLE 24. BIONIME: KEY EXECUTIVES
TABLE 25. BIONIME: COMPANY SNAPSHOT
TABLE 26. BIONIME: OPERATING SEGMENTS
TABLE 27. BIONIME: PRODUCT PORTFOLIO
TABLE 28. BIONIME: KEY STRATERGIES
TABLE 29. SINOCARE: KEY EXECUTIVES
TABLE 30. SINOCARE: COMPANY SNAPSHOT
TABLE 31. SINOCARE: OPERATING SEGMENTS
TABLE 32. SINOCARE: PRODUCT PORTFOLIO
TABLE 33. SINOCARE: KEY STRATERGIES
TABLE 34. MEDTRONIC: KEY EXECUTIVES
TABLE 35. MEDTRONIC: COMPANY SNAPSHOT
TABLE 36. MEDTRONIC: OPERATING SEGMENTS
TABLE 37. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 38. MEDTRONIC: KEY STRATERGIES
TABLE 39. LIFESCAN: KEY EXECUTIVES
TABLE 40. LIFESCAN: COMPANY SNAPSHOT
TABLE 41. LIFESCAN: OPERATING SEGMENTS
TABLE 42. LIFESCAN: PRODUCT PORTFOLIO
TABLE 43. LIFESCAN: KEY STRATERGIES
TABLE 44. ACON LABORATORIES: KEY EXECUTIVES
TABLE 45. ACON LABORATORIES: COMPANY SNAPSHOT
TABLE 46. ACON LABORATORIES: OPERATING SEGMENTS
TABLE 47. ACON LABORATORIES: PRODUCT PORTFOLIO
TABLE 48. ACON LABORATORIES: KEY STRATERGIES
TABLE 49. YPSOMED HOLDING AG: KEY EXECUTIVES
TABLE 50. YPSOMED HOLDING AG: COMPANY SNAPSHOT
TABLE 51. YPSOMED HOLDING AG: OPERATING SEGMENTS
TABLE 52. YPSOMED HOLDING AG: PRODUCT PORTFOLIO
TABLE 53. YPSOMED HOLDING AG: KEY STRATERGIES